Soligenix (SNGX) Competitors

Soligenix (NASDAQ:SNGX) and Q32 Bio (NASDAQ:QTTB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, community ranking, valuation, analyst recommendations, media sentiment and institutional ownership.

Do analysts recommend SNGX or QTTB?

Q32 Bio has a consensus target price of $24.71, suggesting a potential upside of 1,531.31%. Given Q32 Bio's stronger consensus rating and higher possible upside, analysts clearly believe Q32 Bio is more favorable than Soligenix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Soligenix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Q32 Bio	0 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Which has better valuation & earnings, SNGX or QTTB?

Soligenix has higher revenue and earnings than Q32 Bio. Soligenix is trading at a lower price-to-earnings ratio than Q32 Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Soligenix	$840K	5.96	-$6.14M	-$6.11	-0.33
Q32 Bio	-$6.65M	-2.78	-$112.96M	-$10.37	-0.15

Do institutionals and insiders hold more shares of SNGX or QTTB?

3.6% of Soligenix shares are owned by institutional investors. Comparatively, 31.3% of Q32 Bio shares are owned by institutional investors. 2.8% of Soligenix shares are owned by insiders. Comparatively, 16.1% of Q32 Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is SNGX or QTTB more profitable?

Q32 Bio has a net margin of 0.00% compared to Soligenix's net margin of -1,473.38%. Q32 Bio's return on equity of -146.18% beat Soligenix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Soligenix	-1,473.38%	-223.29%	-74.18%
Q32 Bio	N/A	-146.18%	-54.49%

Does the media favor SNGX or QTTB?

In the previous week, Soligenix had 2 more articles in the media than Q32 Bio. MarketBeat recorded 6 mentions for Soligenix and 4 mentions for Q32 Bio. Q32 Bio's average media sentiment score of 0.72 beat Soligenix's score of -0.25 indicating that Q32 Bio is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Soligenix	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
Q32 Bio	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, SNGX or QTTB?

Soligenix has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500. Comparatively, Q32 Bio has a beta of -0.17, meaning that its share price is 117% less volatile than the S&P 500.

Does the MarketBeat Community prefer SNGX or QTTB?

Soligenix received 266 more outperform votes than Q32 Bio when rated by MarketBeat users. Likewise, 72.97% of users gave Soligenix an outperform vote while only 63.16% of users gave Q32 Bio an outperform vote.

Company	Underperform	Outperform
Soligenix	Outperform Votes 278 72.97%	Underperform Votes 103 27.03%
Q32 Bio	Outperform Votes 12 63.16%	Underperform Votes 7 36.84%

Summary

Q32 Bio beats Soligenix on 10 of the 18 factors compared between the two stocks.